Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $16.74, but opened at $16.25. Terumo shares last traded at $16.88, with a volume of 575 shares.
Terumo Price Performance
The business has a fifty day moving average price of $18.24 and a 200-day moving average price of $18.55. The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $24.61 billion, a PE ratio of 31.96 and a beta of 0.79.
Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). Terumo had a net margin of 11.28% and a return on equity of 8.48%. The company had revenue of $1.79 billion during the quarter, compared to the consensus estimate of $1.79 billion.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Read More
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
